Neurosterix raised $63M in a Series A funding led by Perceptive Xontogeny Venture Fund II to advance allosteric modulator therapeutics for neurological disorders.
Amount Raised
$63 Million
Round Type
Series A
New YorkBiotechnologyHealth CareTherapeuticsPharmaceuticalInvestors
Description
Neurosterix launched with a $63 million Series A financing led by Perceptive Xontogeny Venture Fund II, with participation from Perceptive Life Sciences Fund and Acorn Bioventures. Neurosterix is leveraging decades of investment made by Addex in building a leading allosteric modulator discovery technology platform.
Quick answer
Neurosterix raised $63 Million in a Series A round, dated April 3, 2024. Investors: Acorn Bioventures, Perceptive Life Sciences Fund and Perceptive Xontogeny Venture Fund II. Neurosterix is based in New York, New York, United States.
- How much did Neurosterix raise?
- Neurosterix raised $63 Million in a Series A round on April 3, 2024.
- Who invested in Neurosterix?
- Acorn Bioventures, Perceptive Life Sciences Fund and Perceptive Xontogeny Venture Fund II are named as investors in this round.
- What does Neurosterix do?
- Neurosterix is a biopharmaceutical company focused on developing allosteric modulators for the treatment of patients suffering from neurological disorders.
- Where is Neurosterix based and how big is it?
- Neurosterix is based in New York, New York, United States.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Neurosterix that raised within 45 days of this round, from Fundz verified event records.
- Ajax Therapeutics, Inc. raised $95M (Series C) on May 13, 2024.
- Cerenome, Inc. raised $18M (Post-IPO Equity) on May 6, 2024.
- Ajax Therapeutics, Inc. raised $95M on April 26, 2024.
- Brise Pharmaceuticals LTD raised $20M (Funding Round) on April 23, 2024.
- TORL BioTherapeutics raised $158M (Series B) on April 10, 2024.
- TORL BioTherapeutics raised $158M on April 4, 2024.
Who to call at Neurosterix, and when
A new round usually means Neurosterix is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Neurosterix raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Neurosterix, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Neurosterix. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Neurosterix raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansNeurosterix raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.